180x Filetype XLSX File size 0.11 MB Source: cgdevelopmentframework.com
Sheet 1: Overall Instructions
CG Toolkit for banks, NBFIs and MFIs To adequately answer the three CG related questions at the CIP stage, namely: 1a) Was a CG Officer Consulted on the Potential CG Risks of the Deal? 1b) Is a CG Officer to Be Involved During Due Diligence? 2.) Is a CG Review to Be Drafted for the FP by the investment team? the investment team has to conduct a rapid risk screening for each of the five CG risk areas (commitment, board structure, control environment, transparency & disclosure, shareholder rights). Of note is that start-up deals under project finance and SPVs (mainly in the Energy Department), as well as investments in funds are entirely exempted from this exercise. The CIP CG Rapid Risk Screening Tool is the tool prepared to complete this exercise as outlined below. The information can either come from the KYC-file or the annual report of the client. It is not foreseen to conduct an additional research specifically on CG, yet if the answer to a question is not known it also counts as 'true', i.e. a potential risk. Of note is further that the risk indication may not be the same as the final risk level attributed at FP stage. The indicators are, however, identical (1=high; 2=moderate; 3=low). The overall risk indication should guide the investment team focus its forthcoming due diligence on the key CG risk areas. It also has two direct implications at the CIP stage: i) in case there are at least three high (1) risk areas, a CG Officer should be consulted and, depending on the outcome of the consultation, may decide to get involved already during the due diligence process; ii) in most other cases, a CG Review should be undertaken. If there is not at least one high (1) risk area, a CG Review does not have to be undertaken if the proposed loan amount is under 5% of the client's balance sheet. Only very few deals require a consultation with the CG Officer (more than three high risk areas or a direct equity or mezzanine investment at or above 15% ownership for FMO). His or her involvement already during due diligence may be likely if one of the two scenarios is given but depends on the CG Officer's decision based on the consultation. In case of the CG Officer's involvement, the deliverable at FP stage is his or her direct responsibility. The deal team is of course free to consult with the CG Officer in all other cases as well. In case that it only turns out after due diligence that there are indeed three or more high risk areas, which were not properly identified during the CIP stage, the deal team has to again consult the CG Officer to contemplate his or her involvement. While the CG Officer may only be directly involved in half a dozen deals every year, most deals should have a CG Review undertaken by the investment team regardless of the number of high risk areas. Except for the exceptions mentioned above, namely i) green-field or start-up deals and ii) investments in funds, only loans equal or under 5% of the client's balance sheet (AND) are further exempted--but only if not one single or more high CG risk indication(s) exists. |
In case of a CG Review, the CG Progression Matrix and the Questionnaire guide further arriving at a final risk level attribution for each of the categories mentioned in the CG Result Matrix for the FP stage. Of note is that the levels of the CG Progression Matrix do not translate directly into the risk attribution of 1: high risk; 2: moderate risk; and 3: low risk. The IO needs to consider the overall size, industry and growth trajectory of the client among other factors to make this final judgment. Also the strength of the regulatory environment, in particular on CG, can affect the final score in each of the categories. The CG Progression Matrix in principle lends itself more to identify potential mitigations for the particular risks identified rather than assessing the risk level. |
The CG Result Matrix should be finally filled out as integral part of the FP proposal. There should not only be a final (and potentially different) risk attribution to each category (1=high; 2=moderate; 3=low) but also a qualitative description as to what these CG risks are--at least where the risk is moderate. Also, any deviation in the final risk attribution from the risk indication in the CIP CG Rapid Risk Screening should be explained as well as original 'unknowns'. Of note is that CG risks need to be assessed for each and every of the five categories, the average score is only indicative of the overall risks involved and may be misleading if the company scores very well on some areas. In the final conclusion part of the CG Result Matrix, the investment team could either suggest risk mitigation for identified risks or additional steps needed to be taken to eventually mitigate the CG risks identified (such as involvement of the CG Officer, a CG consultant, etc.). At times, the investment team may decide to simply suggest the acceptance of existing risks, in particular if there is no internal champion within the client that would facilitate the improvement on their governance practices or if the regulatory environment does not allow for improvements. |
CG-T.002-8.0. |
CG Sections in CIP | |||||||
Explanation | |||||||
To adequately answer the three CG-related questions at the CIP stage, the investment team has to conduct a quick risk screening for each of the five areas outlined below. Of note is that start-up deals under project finance and SPVs (mainly in the Energy Department), as well as investments in funds are entirely exempted from this exercise. The CIP CG Rapid Risk Screening Tool is the tool prepared to complete this exercise as outlined below. The information can either come from the KYC-file or the annual report of the client. It is not foreseen to conduct an additional research specifically on CG, yet if the answer to a question is not known it also counts as 'true'. Of note is further that the risk indication may not be the same as the final risk level attributed at FP stage. The indicators are, however, identical (1=high; 2=moderate; 3=low). The overall risk indication should help the investment team focus its forthcoming due diligence on the key CG risk areas. It also has two direct implications at the CIP stage: i) in case there are at least three high (1) risk areas, a CG Officer should be consulted and, depending on the outcome of the consultation, may decide to get involved already during the due diligence process; ii) in case that there is at least one high (1) risk area, a CG Review should be undertaken even if the proposed loan amount is under 5% of the client's balance sheet. Only very few deals require a consultation with the CG Officer (as mentioned, more than three high risk areas or a direct equity or mezzanine investment at or above 15% ownership for FMO). His or her involvement already during due diligence may be likely if one of the two scenarios is given but depends on the CG Officer's decision based on the consultation. In case of the CG Officer's involvement, the deliverable at FP stage is his or her direct responsibility. The deal team is of course free to consult with or involve the CG Officer in other cases as well. In case that it only turns out after due diligence that there are indeed three high risk areas, which were not properly identified during the CIP stage, the deal team has to again consult the CG Officer to contemplate his or her involvement. While the CG Officer may only be directly involved in half a dozen deals every year, most deals should have a CG Review undertaken by the investment team regardless of the number of high risk areas. Except for the exceptions mentioned above, namely i) green-field or start-up deals and ii) investments in funds, only loans equal or under 5% of the client's balance sheet (AND) are further exempted if no high CG risk indication exists. |
|||||||
1a.) Was a CG Officer Consulted on the Potential CG Risks of the Deal? | |||||||
The consultation needs to take place if √ direct equity or mezzanine investment at or above 15% ownership, or √ at least four high risk indications. In all other cases the involvement of a CG Officer at this stage is on a voluntary basis. |
|||||||
If 'yes' under 1a.) then answer the question below; if 'no' under 1a.) go to 2.) directly: | |||||||
1b.) Is a CG Officer to Be Involved During Due Diligence? | |||||||
Indicate 'yes' if √ based on the consultation, the CG Officer decided to be part of the due diligence. Indicate 'no' if √ the CG Officer decided not to be part of the due diligence. |
|||||||
If 'no' under 1a.) or 1b.) then answer the question below, otherwise no need to answer the below: | |||||||
2.) Is a CG Review to Be Drafted for FP by the investment team? | |||||||
Indicate 'yes' if √ direct equity or mezzanine investment, or √ loan amount is above 5% of the balance sheet of the client, or √ at least one high risk indication. Indicate 'no' if √ green-field or start-up project, or √ investment in fund, or √ if no 'yes' indication as above. |
|||||||
The CIP CG Rapid Risk Screening (below): Five questions are posed under each of the five risk areas (commitment, board structure, control environment, transparency &disclosure, minority shareholder rights). If three to five questions under each risk area are answered with 'true', a high (1) risk area is identified. If one to two questions are answered with 'true', then a moderate (2) risk area is identified. Finally, if no question is answered with 'true', only a low risk area is identified. Each risk area is evaluated separately. | |||||||
no reviews yet
Please Login to review.